Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Lakefront Biotherapeutics
Market Cap: €1.6b
A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
LKFT
€24.46
7D
2.9%
1Y
-4.7%